Merck & Co., Inc. (MRK) Earnings History
Annual and quarterly earnings data from 1989 to 2025
Loading earnings history...
MRK EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
MRK Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 72.0% | 36.2% | 28.1% |
| 2024 | 76.3% | 31.5% | 26.7% |
| 2023 | 73.2% | 4.9% | 0.6% |
| 2022 | 70.6% | 30.8% | 24.5% |
| 2021 | 72.0% | 27.1% | 26.8% |
Download Data
Export MRK earnings history in CSV or JSON format
Free sign-in required to download data
Merck & Co., Inc. (MRK) Earnings Overview
As of May 6, 2026, Merck & Co., Inc. (MRK) reported trailing twelve-month net income of $18.25B, reflecting +8.0% year-over-year growth. The company earned $7.34 per diluted share over the past four quarters, with a net profit margin of 28.1%.
Looking at the long-term picture, MRK's 5-year EPS compound annual growth rate (CAGR) stands at +21.2%, indicating exceptional earnings growth. The company achieved its highest annual net income of $18.25B in fiscal 2025, representing a new all-time high.
Merck & Co., Inc. maintains industry-leading profitability with a gross margin of 72.0%, operating margin of 36.2%, and net margin of 28.1%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including PFE ($7.49B net income, 12.4% margin), LLY ($25.27B net income, 31.7% margin), ABBV ($4.23B net income, 6.9% margin), MRK has outperformed on profitability metrics. Compare MRK vs PFE →
MRK Earnings vs Peers
Earnings metrics vs comparable public companies
MRK Historical Earnings Data (1989–2025)
37 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $18.25B | +6.6% | $23.49B | $7.28 | 28.1% | 36.2% |
| 2024 | $17.12B | +4589.6% | $20.22B | $6.74 | 26.7% | 31.5% |
| 2023 | $365M | -97.5% | $2.95B | $0.14 | 0.6% | 4.9% |
| 2022 | $14.52B | +11.3% | $18.28B | $5.71 | 24.5% | 30.8% |
| 2021 | $13.05B | +84.6% | $13.20B | $5.14 | 26.8% | 27.1% |
| 2020 | $7.07B | -28.2% | $5.55B | $2.78 | 17.0% | 13.4% |
| 2019 | $9.84B | +58.2% | $7.93B | $3.82 | 25.2% | 20.3% |
| 2018 | $6.22B | +159.8% | $8.93B | $2.32 | 14.7% | 21.1% |
| 2017 | $2.39B | -38.9% | $6.80B | $0.93 | 6.0% | 16.9% |
| 2016 | $3.92B | -11.8% | $5.50B | $2.04 | 9.8% | 13.8% |
Full MRK Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
Should I Buy MRK Right Now?
Bull case, key risks, Wall St analyst verdict, and what council investors are saying — updated daily.
See MRK's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MRK Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MRK vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonMRK — Frequently Asked Questions
Quick answers to the most common questions about buying MRK stock.
Is MRK growing earnings?
MRK EPS stands at $7.34, with +8.0% growth matching the 5-year CAGR of +21.2%. TTM net income is $18.3B. Earnings trajectory remains consistent.
What are MRK's profit margins?
Merck & Co., Inc. net margin is +28.1%, with operating margin at +36.2%. Above-average margins indicate pricing power.
How consistent are MRK's earnings?
MRK earnings data spans 1989-2025. The current earnings trend is +8.0% YoY. Historical data enables comparison across business cycles.